Structural-Activity relationships of drug classes

0.0(0)
Studied by 6 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/77

encourage image

There's no tags or description

Looks like no tags are added yet.

78 Terms

1
New cards

Antidepressant classes

Tricyclic antipsychotics, SSRI, SNRI, MAOI, noradrenergic and specific serotonergic antidepressants (NaSSA), SARI (serotonin antagonist and reuptake inhibitors

2
New cards

Tricyclic antidepressants

amitriptyline, imipramine

3
New cards

Tricyclic antidepressants MoA

Inhibit SERT and NET, increased serotonin and noradrenaline levels

4
New cards

SSRI drugs

Fluoxetine, paroxetine

5
New cards

SSRI MoA

Selective SERT inhibition

6
New cards

SNRI drugs

venlafaxine, duloxetine

7
New cards

SNRI MoA

SERT and NET inhibition

8
New cards

MAOI drug

Moclobemide, tranylcypromine

9
New cards

MAOI MoA

inhibit monoamine oxidase, monoamine neurotransmitter degredation

10
New cards

NaSSA drugs

Mirtazapine

11
New cards

NaSSA MoA

Block presynaptic a2 receptors —> increased Noradrenaline and 5-HT release

12
New cards

SARI drugs

Trazodone, Nefazodone

13
New cards

SARI MoA

5-HT2A antagonism + serotonin reuptake inhibition

14
New cards

5-HT3 antagonists

setrones

15
New cards

Setrone subclasses

carbazone derivates, indazoles, indole derivates, isoquinoline derivates

16
New cards

Setrone drugs

Ondasetrone, granisetron, tropisetron, palonosetron

17
New cards

Setron MoA

Competitive orthosteric antagonists of 5-HT3 ligand gated cation channel

—> prevention of serotonin-induced channel activation

—>antiemetic effect

18
New cards

Migraine drug classes

triptans, titans, gepants

19
New cards

Triptans drugs

sumatriptan, zolmitriptan, eletriptan

20
New cards

Triptans MoA

5-HTB1/D1 agonist—> vasoconstriction

21
New cards

Ditans drugs

Lasmiditan

22
New cards

ditans MoA

Selective 5-HT1F agonist —> inhibits trigeminal signalling and neuropeptide release, without clinically relevant vasoconstriction

23
New cards

Gepants drugs

ubrogepant, rimegepant, atogepant

24
New cards

Gepants MoA

CGRP receptor antagonist—> competitive

in migrain nerve terminals in the trigeminal vascular system release CGRP protein which binds to the receptor causing neurogenic inflammation, vasodilation and transmission of pain signals

<p>CGRP receptor antagonist—&gt; competitive</p><p>in migrain nerve terminals in the trigeminal vascular system release CGRP protein which binds to the receptor causing neurogenic inflammation, vasodilation and transmission of pain signals</p>
25
New cards

Antiepileptic drug classes

Hydantions, Dibenzazepins(carbamazepine), Triazines, gabapentinoids, barbiturates

26
New cards

hydantoins drugs

phenytoin

27
New cards

Hydantoins MoA

stabilize inactivated voltage-gated Na+ channel

28
New cards

Common structural features of phenytoin, carbamazepine, lamotrigine

two benzene rings π–π interaction, Amine π-dipole interactions

<p>two benzene rings <span><em> π–π interaction</em></span>, Amine <em>π-dipole </em>interactions</p>
29
New cards

Dibenzazepines drug

carbamazepine

<p>carbamazepine </p>
30
New cards

Carbamazepine MoA

31
New cards

Triazines drug

Lamotrigine

32
New cards

Triazine MoA

Inbibits voltage-gates Na ´channels

33
New cards

Gabapentanoids drugs

Gabapentin, pregabalin

34
New cards

Gabapentanoids MoA

Bind α₂δ subunit of voltage hated Ca2+ channel, leads to decreased excitatory transmitter release glutamate, noradrenaline and substanse P

35
New cards

Barbiturates drugs

phenobarbital

36
New cards

Barbiturates MoA

positive allosteric GABA-A modulator, increases GABA mediated effects (excitatory neurotransmitter)

37
New cards

Important structures for drugs to interact with Na+ channel, epilepsy

Two aromatic rings and NH for polar interactions

38
New cards

Benzodiazepines MoA

GABA-A positive allosteric modulators → ↑ frequency of GABA-dependent Cl⁻ channel opening

39
New cards

Z-drug drugs, benzodiazepine like hypotics

Zollpidem, zaleplon

40
New cards

Z-drugs MoA

GABA-A positive allosteric modulators → ↑ frequency of GABA-dependent Cl⁻ channel opening

41
New cards
<p>Which functional groups are important for SAR</p>

Which functional groups are important for SAR


<p></p>
42
New cards

Antiparkinsonian drug classes

Dopamine precursor, Peripheral DOPA decarboxylase inhibitors, Dopamine receptor agonist, MAO-B inhibitors, COMT inhibitors, Anticholinergics, NMDA antagonists

<p>Dopamine precursor, Peripheral DOPA decarboxylase inhibitors, Dopamine receptor agonist, MAO-B inhibitors, COMT inhibitors, Anticholinergics, NMDA antagonists</p>
43
New cards

Dopamine precursor drugs

Levodopa

44
New cards

Levodopa MoA

Crosses the BBB and is converted into dopamine in CNS

45
New cards

Peripheral DOPA decarboxylase inhibitors drugs

Carbidopa, benserazinde

46
New cards

Carbidopa MoA

reduce peripheral conversion of Levodopa (levodopa to dopamine) increases the concentration which can reach to brain

47
New cards

NMDA antagonist drugs

Amantadine

48
New cards

NMDA antagonists MoA

Amantadine, Reduces NMDA mediated excitatory signalling, noncompetitive

<p>Amantadine, Reduces NMDA mediated excitatory signalling, noncompetitive</p>
49
New cards

Anticolinergics drugs

trihexyfenidyl, benzotropin, biberidine

50
New cards

Anticolinergic drug MoA

block central muscarinic receptors

51
New cards

which receptor antipsychotics effect

D2, neuroleptics

52
New cards

Antipsychotics classes

phenothiazine, haloperidol, atypical antipsychotics (clozapine,olanzapine), D2 partial agonist (aripiprazole)

53
New cards

Haloperidol MoA

potent D2 antagonism

54
New cards

Atypical antipsychotics drugs and MoA

Clozapine, olanzapine. multireceptor effect, particularly 5-HTsA and D2 antagonism

55
New cards

Aripiprazole MoA

D2 partial agonism, with serotonin receptor activity

56
New cards

Antibiotic groups 11

aminoglycoside, glycopeptides, lipopeptides, macrolides, Azalides (azithromycin), ketolides, tetracyclines, glycylcycline, polypeptides, polymyxins,

57
New cards

Aminoglycosides drug and MoA

streptomycin, gentamycin, tobramycin, kanamycin

—> Bind 30S ribosome, translation errros

58
New cards

Glycopeptides drugs and MoA

Vancomycin, teicoplanin

—> bind D-ala-D-ala of cell wall precursors and inhibit peptidoglycan synthesis

59
New cards

lipopeptides durgs and MoA

Daptomycin, Ca2+ dependent membrane binding and disruption of membrane function

60
New cards

Macrolides drugs and MoA

erythromycin, clarithromycin, roxithromycin

—> bind 50A ribosome, inhibit protein elongation

61
New cards

Azithromycin MoA

50S inhibition, protein elongation

62
New cards

ketolides drugs and MoA

Telithromycin

—> 50s inhibition, protein elongation

63
New cards

tetracyclines drug and MoA

oxytetracycline, doxycycline

—> bind 30S and block aminoacyl-tRNA binding

<p>oxytetracycline, doxycycline</p><p>—&gt; bind 30S and block aminoacyl-tRNA binding </p>
64
New cards

polypeptides drug and MoA

bacitracin

—> blocks recycling of bactoprenol carrier in cell wall synthesis

65
New cards

polymyxins drug and MoA

polymyxin B, polymyxin E (colistin)

—> binds lipoplysaccaharides adn disturbs gram-negative outer membrane

66
New cards

Antifungal classes 4

polyene macrolides, eichinocandins, azoles, allylamines

67
New cards

Polyene macrolides drugs and MoA

Amphotericin B, nystatin

—> bind ergosterol and disrupt fungal membrane

68
New cards

eichinocandins drug and MoA

Caspofungin, micafungin, anidulafungin -fungin

—>Inhibit β-1,3-glucan synthase → impaired fungal cell wall

69
New cards

azoles drugs and MoA

fluconazole, intraconazole

—> inhibit fungal CYP51, decreased ergosterol synthesis

70
New cards

allylamines drug and MoA

terbinafine

—> inhibit squalene epoxidase, enzyme in ergosterol synthesis

71
New cards

influenza antiviral classes

neuramidase inhibitors, Cap-dependent endonuclease inhibitorsne

72
New cards

neuramidase inhib. drugs and MoA

oseltamivir, zanamivir

SIALIC ACID MIMETICS

→ inhibit neuraminidase (surface enzyme) This prevents newly replicated viruses from cleaving from host cells, stopping the spread of the virus throughout the respiratory tract

73
New cards

ACE drugs and MoA

enalapril, captopril, -pril

—> inhibit ACE, reduced angiotensin II leads to vasodilation

74
New cards

β-blockers drugs and MoA

propanolol, metoprolol, bisoprolol

—> Antagonize beta-adrenoceptors, decreased heart rate and cardiac workload

75
New cards

Antiviral mechanisms

entry inhibition, fusion inhibition, nucleoside and nucleotide analogs, non-nucleotide reverse transcript inhibitors, integrate inhibitors, protease inhibitors, neuraminidase inhibitors

76
New cards

integrase inhibition mechanism

blocs integration of HIV DNA into the host genome

77
New cards

protease inhibitors

ritonavir, prevent cleacage of HIV poly proteins —> immature noninfectious virions

78
New cards

neuraminidase inhibitors

competitive inhibition of influenza neuraminidase—> prevent release go new visions

Neuraminidase normally cleaves terminal sialic acids, newly formed virions remain attached or aggregate, reducing viral spread